What ohm Allergy Relief treats: main uses and benefits

The medication is used to address the key symptom clusters associated with allergic reactions, provides supportive relief, and contributes to easing the overall symptom load. This class of medication is commonly used across conditions presenting with acute episodes and those involving episodic or fluctuating manifestations. It is used for managing symptoms related to physical discomfort and symptoms that interfere with daily functioning.

The medicine is applied in addressing situations involving certain distressing symptoms that may appear suddenly or intensify quickly. It is considered relevant when short-term symptomatic assistance is needed to ease discomfort during a flare-up. When groups of symptoms create noticeable functional strain, Allergy Relief may be part of symptomatic management. It supports the management of symptoms that appear suddenly or fluctuate, contributing to improved day-to-day comfort during symptomatic periods. It is relevant across conditions characterized by periods of heightened symptoms.

Quick Fact: Relevant for easing symptoms related to inflammatory or irritative states.

Regulatory References

1. NIH DailyMed Drug Label

The eligibility for ohm Allergy Relief (Loratadine) is determined by mandatory exclusions and restrictions defined in official government regulatory labeling.

---

Contraindicated and Restricted Populations

Category	Official Regulatory Status
Hypersensitivity	Contraindicated in patients with a known allergy to Loratadine or any of the product’s excipients.
Children under 2 years	Contraindicated; safety and efficacy are not established in this age group.
Severe Hepatic Impairment	Restricted use is required; patients with severe liver impairment should be administered a lower initial dose.
Specific Metabolic Disorders	Contraindicated for certain formulations (e.g., lactose-containing tablets) in patients with conditions like galactose intolerance.
Pregnancy and Lactation	Use is not recommended during pregnancy (precautionary measure) and is not recommended while breastfeeding (drug is excreted in breast milk).
Phenylketonuria (PKU)	Caution is advised, as some formulations (e.g., orally disintegrating tablets) may contain phenylalanine.

---

Age-Group Eligibility

• Children 2 to 5 years of age: Eligibility is established, typically for the oral solution formulation.
• Children 6 years of age and older: Approved for use, with the 10 mg tablet strength generally suitable for those with a body weight greater than 30 kg.
• Adults and Older Adults: Generally approved, though underlying severe renal or hepatic impairment requires dose restriction.

Interactions with other medicines and products

This section describes the officially documented interaction patterns for ohm Allergy Relief (Loratadine) found in government regulatory documents.

Interaction Scope	Official Regulatory Documentation
Medicinal product categories with documented interactions:	Enzyme inhibitors (CYP3A4 inhibitors, CYP2D6 inhibitors) and Central Nervous System (CNS) depressants.
Specific interacting medicines (if explicitly listed):	Ketoconazole, Erythromycin, and Cimetidine.
Mechanistic basis of interactions (only if stated in label):	Pharmacokinetic interaction due to inhibition of Cytochrome P450 3A4 (CYP3A4) and Cytochrome P450 2D6 (CYP2D6) metabolism, which are primary pathways for Loratadine clearance.

---

Official interaction statements

• Concomitant use with the specific enzyme inhibitors Ketoconazole, Erythromycin, and Cimetidine substantially increases the plasma concentration of Loratadine.
• Food intake results in a pharmacokinetic change that increases the systemic bioavailability (AUC) of Loratadine by approximately 40%.
• Alcohol co-administration is officially documented as having no potentiating effects on psychomotor performance studies.
• A caution exists regarding additive sedative effects when Loratadine is combined with other CNS depressants.
• Population-Specific Note: Patients with severe hepatic impairment may experience reduced clearance of Loratadine, which can lead to higher systemic exposure.

---

Connection to the overall interaction profile:

Regulatory labeling establishes the interaction profile through documented pharmacokinetic changes. The structure focuses on metabolic inhibition, which identifies specific medicines that elevate Loratadine exposure. The profile also formally documents the effect of food on bioavailability and notes the risk of reduced clearance in the setting of severe hepatic impairment.

How Loratadine Works

Loratadine, the active pharmaceutical ingredient, exerts its action by regulating specific receptor activity and downstream signaling within relevant molecular pathways.

---

Receptor-Mediated Signal Modulation

Loratadine functions primarily as a selective inverse agonist at peripheral histamine H1-receptors. This mechanism involves the drug binding to the H1-receptors found on cells, including those of the vascular smooth muscle and sensory nerves. By binding, loratadine favors the receptor’s inactive state, thereby directly limiting the functional effect of endogenous histamine, a key chemical mediator released during specific physiological responses. The resulting altered H1-receptor signaling modulates the physiological consequences of histamine release, specifically reducing vascular permeability.

---

Modulation of Histamine-Driven Cascades

Intervention at the H1-receptor level modifies early molecular steps that shape systemic physiological output. This blockade occurs within cascades driven by H1-receptor engagement. The consequence is a modulated physiological output characterized by a reduction in the localized histamine-induced wheal and flare responses. The structure of loratadine results in its limited distribution across the blood-brain barrier, restricting its interaction to peripheral H1-receptors.

How to Use ohm Allergy Relief

The usage of ohm Allergy Relief, which contains the active ingredient Loratadine, follows standardized clinical protocols. The medication is designated for oral administration across all approved dosage forms, which include the standard tablet, the liquid solution, and the oral disintegrating tablet.

---

The standard adult regimen, and the dose for children six years of age and older, is 10 mg taken once daily. This frequency is consistent across formulations and is designed to provide sustained 24-hour coverage. The medication may be taken without regard to the timing of meals. Liquid formulations must be measured precisely using a calibrated dosing device to ensure administration of the correct volume and strength.

---

Administration Constraints

The most important usage adjustments are tied to specific clinical scenarios:

• Organ Impairment: For patients with severe hepatic impairment or those with severe renal impairment (glomerular filtration rate <30 mL/min), the standard 10 mg dose must be administered on an every other day schedule. This adjustment extends the interval to mitigate accumulation.
• Allergy Testing: The use of Loratadine should be discontinued at least 48 hours before any scheduled allergy skin testing, as its presence may suppress the expected positive result, thereby compromising the diagnostic accuracy of the procedure.

Older adults typically require no specific dosage adjustment based on age alone. The key principle governing usage is the fixed, non-titrated, once-daily oral administration, adjusted only by extending the interval for identified patient groups.

Research Evidence / Overview of Studies for ohm Allergy Relief

---

Evidence Supporting Use in Allergic Rhinitis (Hay Fever)

Research for Loratadine, the active component of ohm Allergy Relief, has primarily involved Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time by comparing the medication to an inactive substance or to other similar allergy medications. These trials applied in studies examining patient-reported experiences related to allergic rhinitis, a condition characterized by fluctuating or episodic manifestations.

The studies explored various outcomes related to physical discomfort, such as the severity of sneezing, runny nose, and itching in the nose and eyes. Studies monitored patient-reported outcomes describing perceived discomfort and evaluated functional measures, examining changes in daily functioning or activity level. Research describes patterns observed in the studies related to measurements taken of these key allergy symptoms during the short-term study period. However, existing studies provide limited insight into the assessment of nasal congestion.

---

Evidence Supporting Use in Chronic Idiopathic Urticaria (Hives)

Loratadine was also evaluated in studies examining patient-reported experiences associated with Chronic Idiopathic Urticaria (CIU), a condition involving periods of heightened symptoms often referred to as hives. Research examined patient-reported outcomes related to physical discomfort observed in this condition. Studies monitored measurements taken during the study period, focusing primarily on the intensity of pruritus (itching) and the physical characteristics of the rash, specifically the number and size of visible wheals (hives).

Research describes that findings indicate research highlights the measurements taken during the study period for these specific endpoints. The compound was observed in some studies that assessed short-term or episodic symptom patterns of CIU. The data largely involves studies observing responses over defined time intervals that are consistent with acute episodes, and research has not included the study of the underlying cause of the chronic condition.

---

Areas of Research Uncertainty and Study Limitations

The research base for Loratadine mainly consists of short-term clinical trials, typically lasting between 10 days and four weeks. Follow-up durations were limited in the core efficacy trials. Long-term effects are not fully established, meaning the evidence contributes to the broader evidence landscape but research exploring short-term symptom changes provides limited context for continuous, multi-year use. Furthermore, while some pediatric data exists, data for certain younger groups remain insufficient, and research is ongoing to fully characterize use and appropriate symptomatic management.

Key Studies & References Loratadine Tablet Official Label Information (DailyMed/NIH)

Common questions about ohm Allergy Relief (FAQ)

Q: Is ohm Allergy Relief intended for daily long-term use, or is it only for occasional, as-needed relief?

Regulatory documents describe the medication as intended for the temporary relief of symptoms due to hay fever and other allergies. The approved regimen specifies a once-daily dose. The official label does not establish a maximum duration for this temporary-relief use.

Q: Why might someone feel dizzy or drowsy after taking ohm Allergy Relief?

The drug is typically described as non-sedating because it has limited access to the central nervous system. However, official safety information indicates that feeling tired or drowsy is a potential side effect for some people. This effect is reported to be more likely if an individual takes more than the recommended amount.

Q: Are there specific food types that are known to interfere with how ohm Allergy Relief is absorbed?

Official instructions indicate that the medication may be taken without regard to the timing of meals. Even so, regulatory documents note the importance of discussing the use of this medicine alongside specific foods or beverages with a healthcare professional.

Q: What are the general reasons why ohm Allergy Relief might be considered instead of an older generation antihistamine?

The official mechanism of action describes ohm Allergy Relief as a non-sedating antihistamine. This is due to its chemical structure, which results in limited distribution across the blood-brain barrier compared to older allergy medicines.

Q: Is ohm Allergy Relief primarily metabolized by the liver, and what does this mean for drug safety?

The official label notes that patients with severe liver or kidney impairment are directed to consult a healthcare professional before use. This is because a specific dose adjustment may be required for individuals with severe impairment of these organs.

Q: What specific allergy symptoms is ohm Allergy Relief approved to treat?

Official documents state that ohm Allergy Relief is approved to temporarily relieve symptoms associated with hay fever and other upper respiratory allergies. These symptoms include a runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat.

Q: What are the most commonly reported side effects of ohm Allergy Relief?

According to official product information, common side effects reported during use include headache, feeling tired or drowsy, stomach pain, and dry mouth.

Q: Are there any less common but serious side effects associated with ohm Allergy Relief noted in safety data?

Very rare, more serious effects noted during the post-marketing period have included dizziness, rapid heartbeat (palpitations), and convulsion. Official documents indicate that severe allergic reactions have been reported to occur with the medication.

Q: How quickly should a person expect ohm Allergy Relief to start providing relief?

Official information suggests that while the onset of action may vary among individuals, relief of symptoms is reported to start within approximately 20 to 30 minutes, with the full effect typically occurring within one hour of administration.

Q: Are there any known interactions between ohm Allergy Relief and common over-the-counter pain relievers?

Official safety data indicates that Loratadine alone has minimal drug interactions. However, official safety materials emphasize the importance of providing a complete list of medicines being used to a healthcare professional, including common over-the-counter pain relievers.

Q: Can ohm Allergy Relief be taken safely with blood pressure or heart medication?

According to safety reviews, Loratadine alone is generally not identified as concerning for patients with hypertension and does not typically increase blood pressure. Official materials provide warnings regarding combination products that include a decongestant, as these can carry a risk of elevating blood pressure.

Q: What specific types of drug-drug interactions are listed in the official documents for ohm Allergy Relief?

Official documentation notes that interactions may occur with certain medicines that affect liver enzymes. These specific drugs include the antifungal Ketoconazole, the antibiotic Erythromycin, and the heartburn medicine Cimetidine.

Q: What are the official guidelines regarding the use of ohm Allergy Relief during pregnancy or while breastfeeding?

Official guidance states that use during pregnancy is conditional and should only occur if the potential benefit is judged to outweigh the potential risk. For those breastfeeding, use is generally not recommended as the drug is known to be excreted into human milk.

Q: Does ohm Allergy Relief require a prescription in most major countries?

The medication is classified as an Over-The-Counter (OTC) product in the US and is widely available without a prescription in many other countries.

Q: What does the available research evidence indicate about the overall effectiveness of ohm Allergy Relief for allergy symptoms?

Clinical studies submitted to regulatory bodies indicate the drug provides relief of symptoms associated with allergic rhinitis when compared to a placebo.

Q: Is it true that alcohol should be limited or avoided while using ohm Allergy Relief?

Regulatory documents emphasize the importance of consulting a healthcare professional regarding the use of this medicine with alcohol before use.

Q: Are there any known interactions between ohm Allergy Relief and common dietary supplements like vitamins or herbal products?

Official product information emphasizes informing a healthcare professional about all medicines being used. This includes any vitamins, herbs, or supplements being taken.

Q: Is there information about using ohm Allergy Relief for chronic urticaria (hives) or conditions other than seasonal allergies?

Yes, official indications state the drug is also approved to relieve symptoms of chronic idiopathic urticaria. This condition is commonly known as hives or a skin rash consisting of wheals.

Q: Does taking ohm Allergy Relief impact performance on activities like driving or operating machinery?

Although the medication is non-sedating for most users, official warnings indicate the need for caution. Because some individuals may still experience drowsiness or tiredness, it is noted that caution may be necessary before driving or operating machinery until they know how the medication affects them.

Q: Why do some official sources mention a risk of dry mouth or dry eyes with ohm Allergy Relief?

Dry mouth is explicitly listed in the official patient information as one of the common side effects of the medication.

Q: What is the typical appearance (color, shape) of the ohm Allergy Relief tablet or capsule?

The physical characteristics, such as the color and shape of the authorized dosage forms (tablet, liquid, etc.), are typically described in detail in the official DailyMed label's product description section.

Q: Does ohm Allergy Relief treat symptoms caused by both indoor and outdoor allergy triggers?

The drug is approved to treat symptoms due to both seasonal allergic rhinitis (often caused by outdoor triggers) and perennial allergic rhinitis (caused by year-round triggers, often indoor).

Q: How is the drug purpose of ohm Allergy Relief officially described by regulatory bodies?

The official purpose is described by regulatory bodies as an Antihistamine. It is intended to temporarily relieve allergy symptoms.

Q: What are the specific contraindications listed for ohm Allergy Relief (populations who absolutely should not use it)?

Official warnings state the product is contraindicated for individuals with a known allergic reaction to the product or its ingredients.

Q: Do official prescribing documents discuss the use of ohm Allergy Relief for perennial (year-round) allergies?

Yes, official documents state the medication is used to relieve symptoms associated with perennial allergic rhinitis. This term refers to year-around allergy symptoms.

Q: What official safety classification has been given to ohm Allergy Relief by major drug agencies?

Major drug agencies assign classifications to drugs for use in special populations. For example, the Australian Therapeutic Goods Administration (TGA) assigned the pregnancy classification of Category B1 to this drug.

Q: Is it considered normal to experience mild headaches when first starting treatment with ohm Allergy Relief?

According to official product information, headache is noted as one of the common side effects of the medication.

Q: What is the evidence base behind the claimed 24-hour duration of effect for ohm Allergy Relief?

The claimed 24-hour duration is supported by regulatory submissions and clinical studies. These studies examine the sustained blocking effect of the drug on reactivity to histamine over a full 24-hour period.

Q: Where can I find the full official prescribing information or patient leaflet for ohm Allergy Relief?

The full official prescribing information for the product, including the patient leaflet, is made available through government public health resources. Examples include the FDA's DailyMed database or the EMA's electronic package inserts.

Official Storage and Handling Requirements

Ohm Allergy Relief (Loratadine) must be stored within the strict guidelines defined by regulatory labeling to maintain stability.

Requirement	Official Statement
Temperature	Store at controlled room temperature between 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C [Source: FDA/NIH DailyMed].
Protection	Keep the medicine in its original container, tightly closed, and away from excess heat and moisture. Liquid forms must be kept from freezing [Source: NIH MedlinePlus].
Child-Safety	The product must be stored out of the sight and reach of children [Source: NIH MedlinePlus].

Official Disposal Rules

Expired or unused medicine should not be flushed down the toilet or poured into a drain unless the product labeling explicitly instructs otherwise [Source: FDA Guidance]. Disposal should follow official guidelines, utilizing a drug take-back program whenever available [Source: FDA Guidance]. If no take-back program exists, the drug should be mixed with an undesirable substance, sealed, and discarded with household trash [Source: FDA Guidance].